PanVariants: Best Practice for Pangenome-based Variant Calling Pipeline and Framework

preprint OA: closed
Full text JSON View at publisher

Abstract

Background: Although pangenome references offer richer population diversity compared to linear references, current mainstream pangenome-based variant callers are limited to detecting only known variants stored in the graph. To address this limitation, we developed PanVariants, a novel pipeline designed to improve the detection of both known and novel variants accurately. We systematically evaluated its performance against the traditional linear alignment solution (BWA+GATK/Manta) and the existing pangenome-aware solution (DRAGEN/PanGenie) in three contexts: small variants (SNVs/indels) and structural variants (SVs) accuracy in Genome in a Bottle samples, clinical detection on positive samples, and application in cohort-based joint calling. Results: By integrating k-mer-based and mapping‑based methods, PanVariants significantly reduced variant errors (FPs + FNs), achieving a 73% reduction compared to BWA+GATK and a 45% reduction compared to DRAGEN for SNVs. Retraining the DeepVariant model with high-quality DNBSEQ data further decreased errors by 15%. For SVs detection, PanVariants attained an F1-score of 89.39%, markedly outperforming DRAGEN (68.18%) and BWA+Manta (58.33%), approaching long-read sequencing performance (95.22%). In validation using clinical positive samples, PanVariants successfully detected all expected pathogenic variants while PanGenie failed. In the cohort joint‑calling analysis, PanVariants detected more variants, made fewer Mendelian inheritance errors, and gave better per‑sample accuracy than GATK. Conclusions: PanVariants establishes a robust framework and best-practice pipeline for pangenome-based variant detection, achieving both sensitive novel variant discovery and high accuracy for SNVs, indels and SVs. Our systematic evaluation of optional processing steps and input variables offers practical guidance for users. Validated across diagnostic and population-based applications, our findings strongly support the transition from linear to pangenome references in future genomics.
Full text 2,421 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Background Although pangenome references offer richer population diversity compared to linear references, current mainstream pangenome-based variant callers are limited to detecting only known variants stored in the graph. To address this limitation, we developed PanVariants, a novel pipeline designed to improve the detection of both known and novel variants accurately. We systematically evaluated its performance against the traditional linear alignment solution (BWA+GATK/Manta) and the existing pangenome-aware solution (DRAGEN/PanGenie) in three contexts: small variants (SNVs/indels) and structural variants (SVs) accuracy in Genome in a Bottle samples, clinical detection on positive samples, and application in cohort-based joint calling.

Results

By integrating k-mer-based and mapping-based methods, PanVariants significantly reduced variant errors (FPs + FNs), achieving a 73% reduction compared to BWA+GATK and a 45% reduction compared to DRAGEN for SNVs. Retraining the DeepVariant model with high-quality DNBSEQ data further decreased errors by 15%. For SVs detection, PanVariants attained an F1-score of 89.39%, markedly outperforming DRAGEN (68.18%) and BWA+Manta (58.33%), approaching long-read sequencing performance (95.22%). In validation using clinical positive samples, PanVariants successfully detected all expected pathogenic variants while PanGenie failed. In the cohort joint-calling analysis, PanVariants detected more variants, made fewer Mendelian inheritance errors, and gave better per-sample accuracy than GATK.

Conclusions

PanVariants establishes a robust framework and best-practice pipeline for pangenome-based variant detection, achieving both sensitive novel variant discovery and high accuracy for SNVs, indels and SVs. Our systematic evaluation of optional processing steps and input variables offers practical guidance for users. Validated across diagnostic and population-based applications, our findings strongly support the transition from linear to pangenome references in future genomics. Competing Interest Statement L.Q. Wang, X.R. Chen, Y. Ding, L.Y. Xu, X.J. Zeng, X. Zhao, M.H. Gong, X.F. Wei, and M. Ni are employees of MGI. Y. Hou is an employee of BGI Genomics. A. Carroll, P.-C. Chang, and K. Shafin are employees of Google LLC. H. Yi is an intern at MGI Tech. L.Y. Xu was an intern at MGI Tech during the study. Footnotes Insert figures into the full text.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00